PLAT and Stroke: In a randomized controlled study in A Very Early Rehabilitation Trial for stroke (AVERT), Bernhardt used subgroup analyses in patients receiving recombinant tissue plasminogen activator and found similar results, namely, no significantly favorable functional outcome at 3 months was observed in early rehabilitation group (10).